Shenzhen Third People's Hospital

This large, Phase 3 trial is testing a new, shorter combination of drugs to treat all types of active lung tuberculosis, including drug-resistant strains. The goal is to see if this 'pan-TB' regimen can safely cut treatment time from the current 4-6 months down to just 2-3 months…